The IARC Perspective on Cervical Cancer Screening. Issue 3 (March 2022)

• Record Type: Journal Article
• Authors: Bouvard, Véronique; Wentzensen, Nicolas; Mackie, Anne; Berkhof, Johannes; Brotherton, Julia; Giorgi-Rossi, Paolo; Kupets, Rachel; Smith, Robert; Arrossi, Silvina; Bendahhou, Karima; Canfell, Karen; Chirenje, Z. Mike; Chung, Michael H.; del Pino, Marta; de Sanjosé, Silvia; Elfström, Miriam; Franco, Eduardo L.; Hamashima, Chisato; Hamers, Françoise F.; Herrington, C. Simon; Murillo, Raúl; Sangrajrang, Suleeporn; Sankaranarayanan, Rengaswamy; Saraiya, Mona; Schiffman, Mark; Zhao, Fanghui; Arbyn, Marc; Prendiville, Walter; Indave Ruiz, Blanca I.; Mosquera-Metcalfe, Isabel; Lauby-Secretan, Béatrice;
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 3(2022)
• Page Start: 154
• Page End: 156
• Publication Date: 2022-03
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/OGX.0000000000001017
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from N Engl J Med 2021;385:1908–1918) In May 2018, the World Health Organization (WHO) called for the elimination of global cervical cancer as a major public health priority, with a 2-pronged approach focusing on effective vaccination against human papillomavirus (HPV) and the screening for and treatment of early cervical cancer. Cervical cancer is considered largely preventable through these programs; however, it continues to be disproportionately prevalent in countries with the lowest values on the Human Development Index.